• Home
  • News
  • Fortune 500
  • Tech
  • Finance
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
ConferencesThe CEO Initiative

How Pfizer’s CEO ruthlessly cut bureaucracy to deliver a COVID vaccine in record time

By
Alyssa Newcomb
Alyssa Newcomb
Down Arrow Button Icon
By
Alyssa Newcomb
Alyssa Newcomb
Down Arrow Button Icon
November 16, 2021, 11:15 AM ET

Pfizer has undoubtedly changed the world with its COVID-19 vaccine, which has been injected into millions of arms globally in an effort to stop the spread of the virus and keep people healthy.

Last year, the pharmaceutical company’s teams worked at record speed to develop and test an mRNA vaccine, which uses the information in a person’s cells to make a protein that triggers an immune response.

“It was a time that the world was really scared. It was a time we were all living things we had never lived before, never thought we would live,” Pfizer chairman and CEO Dr. Albert Bourla told the audience at Fortune’s CEO Initiative on Monday in Washington, D.C.

Saving lives and ending lockdowns were huge motivators, of course. But Bourla credits certain strategic decisions made by the company with helping it move more quickly toward a vaccine.

The CEO says Pfizer focused on ending internal and external bureaucracy that would otherwise slow its scientists down. The drugmaker didn’t take money from the government, because Bourla said Pfizer scientists would then have to lose time in committee meetings meticulously detailing how they were spending public funding. 

Bourla also made sure to embed himself with teams so decisions could be made faster. 

In organizations, “because of the silos, it is very difficult to make decisions,” he said. Having the CEO or another executive in meetings helped speed up Pfizer’s process. 

Pfizer’s team also operated with a sense of purpose, which he said was framed by the question: “If not us, then who?”

“It was a time that the people needed to rise to the occasion, no matter what,” said Bourla. 

One year after the first vaccine trial results were released, Pfizer’s impact has been undeniable. In addition to the vaccine, Pfizer also has an antiviral pill.

“If we didn’t have a vibrant life sciences sector, we wouldn’t be here today,” said the CEO.

More health care and Big Pharma coverage from Fortune:

  • Biden’s vaccine mandate may be tied up in court—but employers shouldn’t wait to enforce it, say legal experts
  • State Farm publicly supports NFL’s Aaron Rodgers after his vaccine comments—while quietly removing most of his ads
  • How Big Bird became the unlikely target of GOP senators
  • Denmark ditched its COVID rules 2 months ago. Now cases are up—and restrictions are coming back
  • Air purifiers and CO2 monitors are the new pencil and paper in classrooms

Subscribe to Fortune Daily to get essential business stories delivered straight to your inbox each morning.

About the Author
By Alyssa Newcomb
See full bioRight Arrow Button Icon

Latest from our Conferences

Workplace CultureBrainstorm Design
How two leaders used design thinking and a focus on outcomes to transform two Fortune 500 giants
By Christina PantinDecember 4, 2025
24 hours ago
Workplace CultureBrainstorm Design
Designer Kevin Bethune: Bringing ‘disparate disciplines around the table’ is how leaders can ‘problem solve the future’
By Fortune EditorsDecember 3, 2025
2 days ago
AIBrainstorm Design
Microsoft AI’s design head wants her team to be AI-native by the end of the fiscal year
By Angelica AngDecember 3, 2025
2 days ago
AsiaFortune Innovation Forum
Syfe CEO: Fintech founders need to focus on trust if the sector is to reach its full potential
By Dhruv AroraNovember 24, 2025
10 days ago
EnergyFortune Innovation Forum
Going green doesn’t always mean going big: ‘Pay attention to the small- and medium-size players as well’
By Angelica AngNovember 24, 2025
11 days ago
AsiaFortune Innovation Forum
A World Bank expert thinks countries should leverage ‘small AI’—and avoid competing with the biggest tech giants
By Nicholas GordonNovember 24, 2025
11 days ago

Most Popular

placeholder alt text
Economy
Two months into the new fiscal year and the U.S. government is already spending more than $10 billion a week servicing national debt
By Eleanor PringleDecember 4, 2025
19 hours ago
placeholder alt text
Success
‘Godfather of AI’ says Bill Gates and Elon Musk are right about the future of work—but he predicts mass unemployment is on its way
By Preston ForeDecember 4, 2025
14 hours ago
placeholder alt text
North America
Jeff Bezos and Lauren Sánchez Bezos commit $102.5 million to organizations combating homelessness across the U.S.: ‘This is just the beginning’
By Sydney LakeDecember 2, 2025
3 days ago
placeholder alt text
Success
Nearly 4 million new manufacturing jobs are coming to America as boomers retire—but it's the one trade job Gen Z doesn't want
By Emma BurleighDecember 4, 2025
15 hours ago
placeholder alt text
Success
Nvidia CEO Jensen Huang admits he works 7 days a week, including holidays, in a constant 'state of anxiety' out of fear of going bankrupt
By Jessica CoacciDecember 4, 2025
14 hours ago
placeholder alt text
Health
Bill Gates decries ‘significant reversal in child deaths’ as nearly 5 million kids will die before they turn 5 this year
By Nick LichtenbergDecember 4, 2025
1 day ago
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.